arrow_back Back to App

Tardive Dyskinesia Awareness Week: Boosting Knowledge of a Movement Disorder

The U.S. House of Representatives designated May 1-7, 2022, as "Tardive Dyskinesia Awareness Week." This aims to increase public and medical community knowledge about this movement disorder, which can affect individuals taking certain medications for mental health or gastrointestinal issues. The initiative seeks to improve recognition and treatment of tardive dyskinesia, potentially enhancing the quality of life for patients and caregivers.
Key points
Designating Tardive Dyskinesia Awareness Week aims to educate the public about the symptoms and risks of this condition.
Tardive dyskinesia involves involuntary movements that can occur after taking certain medications for mental or gastrointestinal disorders, often going unrecognized.
Increased awareness can lead to earlier diagnosis and better treatment, which is crucial as the condition is often permanent.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_1107
Sponsor: Rep. Peters, Scott H. [D-CA-52]
Process start date: 2022-05-11
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Designating the week of May 1, 2022, through May 7, 2022, as "Tardive Dyskinesia Awareness Week".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1107.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-11.

What are the main provisions?

Key points include:

  • Designating Tardive Dyskinesia Awareness Week aims to educate the public about the symptoms and risks of this condition.
  • Tardive dyskinesia involves involuntary movements that can occur after taking certain medications for mental or gastrointestinal disorders, often going unrecognized.
  • Increased awareness can lead to earlier diagnosis and better treatment, which is crucial as the condition is often permanent.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Peters, Scott H. [D-CA-52].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health